DOI: 10.1128/mSphere.00040-18
Article Information
PubMed
Published By
History
- Published online March 7, 2018.
Copyright & Usage
Copyright © 2018 Koblentz. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Author Information
- Gregory D. Koblentza
- Address correspondence to gkoblent{at}gmu.edu.
Citation Koblentz GD. 2018. A critical analysis of the scientific and commercial rationales for the de novo synthesis of horsepox virus. mSphere 3:e00040-18. https://doi.org/10.1128/mSphere.00040-18.
Article usage
- Top
- Article
- ABSTRACT
- COMMENTARY
- EVALUATING THE SCIENTIFIC AND COMMERCIAL RATIONALES FOR SYNTHESIZING HORSEPOX VIRUS
- WEAK SCIENTIFIC BASIS FOR HORSEPOX VIRUS STRAIN MNR-76 AS ANCESTRAL STRAIN FOR VACCINIA
- WEAK SCIENTIFIC BASIS THAT HORSEPOX VIRUS WOULD BE SAFER ALTERNATIVE FOR HUMAN VACCINE USE
- NO DEMONSTRATED NEED FOR A SAFER SMALLPOX VACCINE
- NO DEMAND FOR A NEW SMALLPOX VACCINE
- CONCLUSION
- ACKNOWLEDGMENTS
- FOOTNOTES
- REFERENCES
- Info & Metrics